NeuralBase AI Ltd. Announces Completion of Android Version for HeartEase App

NeuralBase AI Ltd., under its enterprise brand BMP AI, has announced the completion of the Android version of HeartEase, an AI-powered app designed to offer cardiovascular and emotional health insights. The app is currently undergoing final testing, with a public release anticipated in the coming weeks. Following this, the iOS version is set to enter testing, ensuring feature parity and performance consistency across platforms.

HeartEase utilizes NeuralBase AI’s proprietary AI platform, behavioral insights, and biometric data analysis to deliver an adaptive user experience focused on proactive wellness management. The app’s development represents a critical milestone in NeuralBase AI’s mission to enhance enterprise wellness and preventive health diagnostics through digital health solutions.

Vighnesh Dobale, Chief Executive Officer of NeuralBase AI Ltd., emphasized the importance of this achievement, stating, NeuralBase AI Ltd. is preparing for the iOS testing phase to ensure the app meets the company’s high standards for performance and user experience across all devices.

The launch of HeartEase is expected to validate the platform’s technology in real-world conditions, gather essential user feedback for further refinements, and support potential strategic partnerships with healthcare providers and wearable technology companies. This initiative positions NeuralBase AI to scale its AI-powered digital health ecosystem effectively.

NeuralBase AI Ltd. is committed to keeping stakeholders informed about HeartEase’s release schedule, platform enhancements, and strategic initiatives as testing progresses. Additional information about the company and its filings can be found at the Securities & Exchange Commission.